Last reviewed · How we verify
NCT05661396
Therapeutic Serious Game and Rehabilitation of Stroke Patient
NA trial testing Serious game rehabilitation in Stroke in 6 participants. Completed in 6 September 2017.
3 June 2017
Quick facts
| Lead sponsor | Hopitaux de Saint-Maurice |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 3 November 2016 |
| Primary completion | 3 June 2017 |
| Estimated completion | 6 September 2017 |
Drugs / interventions tested
- Serious game rehabilitation
Conditions studied
- Stroke — all drugs for Stroke →
- Unilateral Spatial Neglect — all drugs for Unilateral Spatial Neglect →
Sponsor
Hopitaux de Saint-Maurice
Who can join
Adults 18 to 80, any sex, with Stroke or Unilateral Spatial Neglect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The growing field of new technologies offers new perspectives for neurorehabilitation. Serious games are a promising solution in the rehabilitation of cognitive impairments, and they may be useful in the rehabilitation of unilateral spatial neglect. The investigators developed a rehabilitation program for visual exploration training with a serious game and investigated its efficiency. Six patients with unilateral spatial neglect after a right hemispheric stroke were recruited. Three patients assigned to the experimental group received both serious game training and conventional rehabilitation, and three assigned to the control group received only conventional rehabilitation. The investigators compared the two groups after rehabilitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05661396
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Hopitaux de Saint-Maurice trials
Trials by the same sponsor.
- NCT07401966 — Amputations in Childhood and Neuropathic Pain · recruiting
- NCT07419217 — Professional Impact of Osteoarticular Trauma · recruiting
- NCT07085403 — Let's CO-OPerate! Together we Are Stronger · NA · not yet recruiting
- NCT05579002 — Evaluation of the Functional Outcome of Hero Arm Prosthesis in Children After One Year of Use. · completed
- NCT04560777 — Exploring the Use of the Cognitive Orientation to Daily Occupational Performance Approach (CO-OP) With Children, Teenage · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05661396 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hopitaux de Saint-Maurice
- Last refreshed: 22 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05661396.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing